NEXT
Sign in to follow
Search Results

0 results for 'Eli Lilly'

You can use to get even better search results
May 21, 2024 | National Law Journal

DC Circuit Sides With Manufacturers in '340B' Drug Discount Dispute

"[W]e cannot plausibly interpret statutory silence to subject manufacturers to whatever delivery conditions any covered entity might find most convenient," Judge Gregory Katsas wrote for the appeals court.
4 minute read
May 20, 2024 | The American Lawyer

Big Law Seeks to Maintain M&A Momentum With Lateral Market Maneuvers

Firms such as Paul Weiss, Sullivan & Cromwell, Akin, K&L Gates and Seyfarth all announced lateral M&A partners in the last week.
5 minute read
May 17, 2024 | Corporate Counsel

Surge in Social Media Drug Promotion Driving Calls for More Oversight

"I think the industry would like more clarity from the FDA on what exactly its position is on its authority over social media," said Mahnu Davar, a partner at Arnold & Porter Kaye Scholer.
7 minute read
May 09, 2024 | The Legal Intelligencer

Judge Expands Ozempic Plaintiffs' Leadership Team, Names 4 Co-Lead Counsel

In a joint statement, the newly appointed leads said they "are honored to have been appointed by Judge Pratter to lead one of the most significant and consequential pharmaceutical injury cases of our time against the manufacturers of diabetes and weight loss drugs such as Ozempic and Wegovy."
3 minute read
April 25, 2024 | New Jersey Law Journal

As Eli Lilly's Insulin Pricing Settlement Unravels, Lawyers Vow to Push Ahead

Lawyers touting a $500 million settlement over insulin pricing are back at the drawing board after a judge refused to certify their class.
5 minute read
April 24, 2024 | The Legal Intelligencer

Ozempic Plaintiffs Get Leadership Team, but Not Quite the One They Asked For

Walsh said that, during an extensive hearing on leadership structure last week, Pratter "had some concerns about the size of the committee that we put in the application."
4 minute read
April 23, 2024 | Connecticut Law Tribune

Civil RICO Suit Accuses Big Pharma and Benefit Managers of Insulin Price-Fixing

"Rather than working to lower insulin and other Type 2 diabetes medication prices, major [pharmacy benefit managers] and manufacturers use their dominant market positions to drastically increase the price of these necessary, life-saving medications, generating billions of dollars in illicit profits," co-lead counsel for the plaintiff claimed in a joint statement.
4 minute read
April 08, 2024 | The Legal Intelligencer

Ozempic Leadership Fight Escalates: Proposed Co-Leads Are 'Losing Control'

Sarah Foster, of Schlesinger Law Offices in Fort Lauderdale, continued to insist she and others were excluded from the Ozempic leadership process, noting the last-minute addition of two lawyers to the proposed team.
6 minute read
April 04, 2024 | The Legal Intelligencer

Under Fire, Ozempic Lawyers Add Two 'Team Players' to Proposed Leadership

Plaintiffs lawyers who assembled a proposed leadership team in Ozempic lawsuits fired back at the accusation that they excluded attorneys—then added two more lawyers to their proposed team.
5 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Strong & Hanni Solves Storage Woes--Learn How You Can, Too

    Brought to you by Filevine

    Download Now

  • Meeting the Requirements of California's SB 553: Workplace Violence Prevention

    Brought to you by NAVEX Global

    Download Now

  • The Benefits of Outsourcing Beneficial Ownership Information Filing

    Brought to you by Wolters Kluwer

    Download Now

  • The Top 10 AI Use Cases in Private Equity

    Brought to you by Ontra

    Download Now